L-Homophe-OH
L-Homophe-OH Basic information
- Product Name:
- L-Homophe-OH
- Synonyms:
-
- (+)-2-Amino-4-phenylbutyric acid,98%
- S)-α-Amino-benzenebutanoic acid
- L-(S)-Homophenylalanine.HCl
- L-Homophenylalanine ,98%
- H-L-HPA-OH
- Benzenebutanoicacid, a-aMino-, (aS)-
- H-HoMophe-OH(HoMophenylalanine)
- RARECHEM BK PT 0049
- CAS:
- 943-73-7
- MF:
- C10H13NO2
- MW:
- 179.22
- EINECS:
- 213-403-3
- Product Categories:
-
- API intermediates
- Homophenylalanine [Hph]
- Amino Acids 13C, 2H, 15N
- Amino Acids & Derivatives
- Aromatics
- Chiral Compounds
- Phenylalanine analogs and other aromatic alpha amino acids
- Chiral Compound
- Amino Acids
- Mol File:
- 943-73-7.mol
L-Homophe-OH Chemical Properties
- Melting point:
- >300 °C(lit.)
- alpha
- 45 º (C=1, 3N HCl 19 ºC)
- Boiling point:
- 311.75°C (rough estimate)
- Density
- 1.1248 (rough estimate)
- refractive index
- 44 ° (C=1, 3mol/L HCl)
- storage temp.
- Keep in dark place,Inert atmosphere,Room temperature
- solubility
- Soluble in dilute aqueous acid.
- pka
- 2.32±0.10(Predicted)
- form
- Solid
- color
- White to Off-White
- InChI
- InChI=1/C10H13NO2/c11-9(10(12)13)7-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/s3
- InChIKey
- JTTHKOPSMAVJFE-VIFPVBQESA-N
- SMILES
- C(O)(=O)[C@H](CCC1=CC=CC=C1)N |&1:3,r|
- CAS DataBase Reference
- 943-73-7(CAS DataBase Reference)
MSDS
- Language:English Provider:(S)-alpha-Amino-benzenebutanoic acid
- Language:English Provider:ACROS
- Language:English Provider:SigmaAldrich
L-Homophe-OH Usage And Synthesis
Description
L-Homophenylalanine is an amino acid derivative. It has been extensively used in the pharmaceutical industry as a precursor for production of angiotensin-converting enzyme (ACE) inhibitor: enalapril, delapril, quinapril and ramipril, which possesses significant clinical application in the management of hypertension and congestive heart failure (CHF). It acts as an anti-tumor reagent.
References
Hwang, J. Y., et al. "Simultaneous synthesis of 2-phenylethanol and L-homophenylalanine using aromatic transaminase with yeast Ehrlich pathway." Biotechnology & Bioengineering 102.5(2009):1323-9.
Ahmad, A. L., P. C. Oh, and S. R. Abd Shukor. "Sustainable biocatalytic synthesis of L-homophenylalanine as pharmaceutical drug precursor."Biotechnology Advances 27.3(2009):286-296.
https://www.alfa.com/en/catalog/H27295/
Application
L-homophenylalanine is used almost exclusively as single stereoisomer in pharmaceutical drug production. L-homophenylalanine as a common building block, due to the presence of L-homophenylalanine moiety as the central pharmacophore unit. L-homophenylalanine is also an important chiral intermediate to synthesize a variety of novel pharmaceuticals including β-lactam antibiotics, acetylcholinesterase inhibitor and neutral endopeptidace (NEP) inhibitor which retained their status as major contributors to human health preservation. L-homophenylalanine acts as a precursor for the synthesis of NEP inhibitors, which complements the effects of ACE inhibitors when used simultaneously, potentiates the outcome in the management of hypertension and congestive heart failure[1].
Chemical Properties
White Solid
Uses
L-Homophenylalanine is used as a precursor in the pharmaceutical industry for the production of angiotensin-converting enzyme (ACE) and R-(-)-Homophenylalanin-ethylester. It is also involved in the synthesis of NEPA [(S,S)-N-(1-Ethoxycarbonyl-3-phenylpropyl)alanine], which is a key intermediate to prepare the ACE-inhibitors: enalapril, delapril, quinapril and ramipril. It acts as an anti-tumor reagent.
Uses
Antitumor agent.
Definition
ChEBI: A non-proteinogenic L-alpha-amino acid that is an analogue of L-phenylalanine having a 2-phenylethyl rather than a benzyl side-chain.
Production Methods
Asymmetric reduction of prochiral ketone remains one of the most investigated methods to date for production of chiral L-homophenylalanine. One of the most established method for synthesizing L-homophenylalanine on a laboratory scale was carried out via enzyme-catalyzed asymmetric synthesis of keto acids. In this method, prochiral ketone was converted via reductive amination to enantiopure products with bulky side chains by addition of biocatalysts such as L-homophenylalanine dehydrogena. in the presence of cofactor. L-phenylalanine dehydrogenase is by and large preferred as it has mainly a catabolic function and accepts a wide variety of keto acids as substrates hence it is generally employed in the synthesis of L-homophenylalanine which carries very bulky side chains[1].
References
[1] Ahmad A, et al. Sustainable biocatalytic synthesis of L-homophenylalanine as pharmaceutical drug precursor. Biotechnology Advances, 2009; 27: 286-296.
L-Homophe-OHSupplier
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 0513-0513-0513-89158300 18014392889
- sales@puyerbiopharma.com
- Tel
- 0523-86132544 15366717810
- sales@thbiochem.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 021-61259108 18621169109
- market03@meryer.com
L-Homophe-OH(943-73-7)Related Product Information
- 4-(4-Aminophenyl)butyric acid
- Boc-D-Tyr-OH
- ALTRENOGEST
- α-Lipoic Acid
- L(+)-Arginine
- Glycine
- Betaine
- 4-Phenylbutyric acid
- METHYL 4-(4-AMINOPHENYL)BUTANOATE
- 4-Aminobutyric acid
- L-Homophenylalanine ethyl ester hydrochloride
- Phenylacetone
- N-[(tert-Butoxy)carbonyl]-D-tryptophan
- FMOC-4-TRIFLUOROMETHYL-D-BETA-HOMOPHENYLALANINE
- BOC-(S)-3-AMINO-4-(4-CHLORO-PHENYL)-BUTYRIC ACID
- [-/+]-2-AMINO-4-PHENYLBUTYRIC ACID,DL-ALPHA-AMINO-4-PHENYLBUTYRIC ACID
- 2,4-DICHLORO-L-BETA-HOMOPHENYLALANINE HYDROCHLORIDE
- N-T-BUTOXYCARBONYL-(S)-3-AMINO-4-PHENYLBUTYRIC ACID,(S)-3-(BOC-AMINO)-4-PHENYLBUTYRIC ACID